These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 14719078

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P, Robey R, Fojo T, Blagosklonny MV.
    Oncogene; 2001 Jun 28; 20(29):3806-13. PubMed ID: 11439344
    [Abstract] [Full Text] [Related]

  • 3. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR, Tucker SA, Huang Z, Gillenwater AM, Luna MA, Batsakis JG, El-Naggar AK.
    Int J Oncol; 2003 Feb 28; 22(2):409-14. PubMed ID: 12527941
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
    Debernardis D, Siré EG, De Feudis P, Vikhanskaya F, Valenti M, Russo P, Parodi S, D'Incalci M, Broggini M.
    Cancer Res; 1997 Mar 01; 57(5):870-4. PubMed ID: 9041188
    [Abstract] [Full Text] [Related]

  • 7. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov 01; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 8. p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells.
    Kang KH, Kim WH, Choi KH.
    Exp Cell Res; 1999 Dec 15; 253(2):403-12. PubMed ID: 10585263
    [Abstract] [Full Text] [Related]

  • 9. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis.
    Peschos D, Stefanou D, Vougiouklakis T, Assimakopoulos DA, Agnantis NJ.
    J Exp Clin Cancer Res; 2005 Sep 15; 24(3):431-7. PubMed ID: 16270530
    [Abstract] [Full Text] [Related]

  • 10. Alteration of the Bcl-2/Bax status of head and neck cancer cell lines by chemotherapeutic agents.
    Kawakami K, Tsukuda M, Mizuno H, Nishimura G, Ishii A, Hamajima K.
    Anticancer Res; 1999 Sep 15; 19(5B):3927-32. PubMed ID: 10628333
    [Abstract] [Full Text] [Related]

  • 11. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ.
    J Exp Clin Cancer Res; 2004 Jun 15; 23(2):277-83. PubMed ID: 15354413
    [Abstract] [Full Text] [Related]

  • 12. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
    Frank DK, Liu TJ, Frederick MJ, Clayman GL.
    Clin Cancer Res; 1998 Sep 15; 4(9):2265-72. PubMed ID: 9748148
    [Abstract] [Full Text] [Related]

  • 13. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM, Hulscher TM, Schrier SM, van Houten VM, Pinedo HM, Boven E.
    Gynecol Oncol; 2002 Mar 15; 84(3):404-12. PubMed ID: 11855878
    [Abstract] [Full Text] [Related]

  • 14. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL, Sinha UK.
    Head Neck; 2006 Jan 15; 28(1):15-23. PubMed ID: 16302195
    [Abstract] [Full Text] [Related]

  • 15. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP, Gazzeri S, Riva C, Reyt E, Brambilla C, Brambilla E.
    Anticancer Res; 1998 Jan 15; 18(6B):4741-9. PubMed ID: 9891551
    [Abstract] [Full Text] [Related]

  • 16. Ketoconazole potentiates the antitumor effects of nocodazole: In vivo therapy for human tumor xenografts in nude mice.
    Wang YJ, Jeng JH, Chen RJ, Tseng H, Chen LC, Liang YC, Lin CH, Chen CH, Chu JS, Ho WL, Ho YS.
    Mol Carcinog; 2002 Aug 15; 34(4):199-210. PubMed ID: 12203371
    [Abstract] [Full Text] [Related]

  • 17. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma.
    Bandoh N, Hayashi T, Takahara M, Kishibe K, Ogino T, Katayama A, Imada M, Nonaka S, Harabuchi Y.
    Acta Otolaryngol; 2005 Jul 15; 125(7):779-85. PubMed ID: 16012042
    [Abstract] [Full Text] [Related]

  • 18. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF, Barberi-Heyob M, Didelot C, Peyrat JP, Abecassis J, Millon R, Merlin JL.
    Br J Cancer; 2000 Nov 15; 83(10):1380-6. PubMed ID: 11044365
    [Abstract] [Full Text] [Related]

  • 19. Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line.
    Alhasan SA, Ensley JF, Sarkar FH.
    Int J Oncol; 2000 Feb 15; 16(2):333-8. PubMed ID: 10639578
    [Abstract] [Full Text] [Related]

  • 20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.